{"id":20793,"date":"2019-01-22T15:34:38","date_gmt":"2019-01-22T23:34:38","guid":{"rendered":"https:\/\/sop.washington.edu\/?p=20793"},"modified":"2019-12-10T11:55:22","modified_gmt":"2019-12-10T19:55:22","slug":"nath-lab-makes-progress-against-neurodegenerative-conditions","status":"publish","type":"post","link":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/nath-lab-makes-progress-against-neurodegenerative-conditions\/","title":{"rendered":"Nath lab makes progress against neurodegenerative conditions"},"content":{"rendered":"
\"Hope
Hope Barnes Fellow and graduate student Hannah Baughman continues to discover more about molecular chaperones and their potential in treating Alzheimer’s disease <\/figcaption><\/figure>\n

We revisited Abhi Nath and his lab team to see how their work to improve the diagnosis and treatments of neurodegenerative conditions, including Alzheimer\u2019s, Parkinson\u2019s, and Chronic Traumatic Encephalopathy (CTE) was progressing.<\/p>\n

The team hopes to discover improved diagnostic tools and therapies by learning how brain proteins such as Tau, \u03b2-Amyloid and \u03b1-Synuclein start misbehaving in these diseases.<\/p>\n

The challenge is that proteins like Tau are very flexible moving targets, almost like Jell-O\u2122, making it hard to use traditional tools of structural biology. One of their long-term goals is to develop new small molecules that can either slow down protein aggregation, or bind to particular types of aggregates to act as a tracer.<\/p>\n

Such tracers or tags can currently be used to detect protein aggregates in brain scans, but struggle to distinguish which particular proteins are involved, or whether aggregates are harmful or benign.<\/p>\n

\n

\u201cNewer, more specific tracers could enable earlier, more accurate diagnosis of conditions like Alzheimer\u2019s and Parkinson\u2019s and ultimately improve outcomes for patients and their families.\u201d–Abhi Nath<\/p>\n<\/blockquote>\n

\"\u201cAlzheimer\u2019s
\u201cAlzheimer\u2019s is such a challenging and scary disease. Any difference we can make there would mean so much\u2014a lot of us have been affected and it\u2019s only going to get worse as the population gets older,\u201d remarks Abhi Nath (pictured right with David Baggett, left) Photo: Alex Levine<\/span><\/figcaption><\/figure>\n

Graduate student David Baggett\u2019s computer models can screen millions of compounds to identify molecules capable of binding proteins like Tau, and either detecting or stopping the aggregation process. As they learn more about how these compounds recognize Tau, they can perhaps engineer more effective, safer variants that could serve as the basis for new treatment and diagnosis strategies.<\/p>\n

A new industry partnership with Takeda Pharmaceutical Co. will accelerate their research. \u201cThe Takeda award provides us with support and resources to work on designing, synthesizing, and testing new molecules\u2014 derivatives of ones that David found,\u201d shared Abhi. \u201cWe will also use his methods to identify other novel molecules with similar activity.\u201d<\/p>\n

Hope Barnes Fellow and graduate student Hannah Baughman continues to discover more about molecular chaperones, which are natural defenders against protein aggregation. The NIH recently elected to support this work under a special program for Alzheimer\u2019s disease and related dementias.<\/p>\n

\u201cIf we can turn up the right sort of activity for the right type of chaperone, that may advance our ability to treat Alzheimer\u2019s, Parkinson\u2019s, and CTE,\u201d said Abhi. \u201cMy vision is to use the advances that have been made in protein biophysics over the past 10\u201315 years to find new ways to diagnose these conditions early and improve treatments and outcomes for patients. Given how much we have learned about Tau and similar proteins, and our partnerships in academia and industry, I am very excited about our prospects.\u201d<\/p>\n

 <\/p>\n

To study with researchers like Dr. Nath with peers like Hannah Baughman<\/strong>, click for\u00a0more information about our\u00a0Graduate Programs in Medicinal Chemistry<\/a>.<\/p>\n

Visit the Nath Lab website<\/a><\/p>\n

Link to Medicinal Chemistry archived news<\/a><\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

We revisited Abhi Nath and his lab team to see how their work to improve the diagnosis and treatments of neurodegenerative conditions, including Alzheimer\u2019s, Parkinson\u2019s, and Chronic Traumatic Encephalopathy (CTE) was progressing. The team hopes…<\/p>\n","protected":false},"author":3,"featured_media":20794,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[32],"tags":[],"class_list":["post-20793","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medchem-news"],"yoast_head":"\nNath lab makes progress against neurodegenerative conditions - School of Pharmacy<\/title>\n<meta name=\"description\" content=\"We revisited Abhi Nath and his lab team to see how their work to improve the diagnosis and treatments of neurodegenerative conditions, including\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/staff.washington.edu\/twentzel\/wordpress\/nath-lab-makes-progress-against-neurodegenerative-conditions\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nath lab makes progress against neurodegenerative conditions - School of Pharmacy\" \/>\n<meta property=\"og:description\" content=\"We revisited Abhi Nath and his lab team to see how their work to improve the diagnosis and treatments of neurodegenerative conditions, including\" \/>\n<meta property=\"og:url\" content=\"https:\/\/staff.washington.edu\/twentzel\/wordpress\/nath-lab-makes-progress-against-neurodegenerative-conditions\/\" \/>\n<meta property=\"og:site_name\" content=\"School of Pharmacy\" \/>\n<meta property=\"article:publisher\" content=\"http:\/\/www.facebook.com\/UWSOP\" \/>\n<meta property=\"article:published_time\" content=\"2019-01-22T23:34:38+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-12-10T19:55:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-content\/uploads\/AL_Hannah_Baughman_lab.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1600\" \/>\n\t<meta property=\"og:image:height\" content=\"1066\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Tim Wentzel\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@UW_Pharmacy\" \/>\n<meta name=\"twitter:site\" content=\"@UW_Pharmacy\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tim Wentzel\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/nath-lab-makes-progress-against-neurodegenerative-conditions\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/nath-lab-makes-progress-against-neurodegenerative-conditions\\\/\"},\"author\":{\"name\":\"Tim Wentzel\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#\\\/schema\\\/person\\\/21859bae0c32073fc2c8d833a054b09f\"},\"headline\":\"Nath lab makes progress against neurodegenerative conditions\",\"datePublished\":\"2019-01-22T23:34:38+00:00\",\"dateModified\":\"2019-12-10T19:55:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/nath-lab-makes-progress-against-neurodegenerative-conditions\\\/\"},\"wordCount\":544,\"publisher\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/nath-lab-makes-progress-against-neurodegenerative-conditions\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/wp-content\\\/uploads\\\/AL_Hannah_Baughman_lab.jpg\",\"articleSection\":[\"Medchem News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/nath-lab-makes-progress-against-neurodegenerative-conditions\\\/\",\"url\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/nath-lab-makes-progress-against-neurodegenerative-conditions\\\/\",\"name\":\"Nath lab makes progress against neurodegenerative conditions - School of Pharmacy\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/nath-lab-makes-progress-against-neurodegenerative-conditions\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/nath-lab-makes-progress-against-neurodegenerative-conditions\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/wp-content\\\/uploads\\\/AL_Hannah_Baughman_lab.jpg\",\"datePublished\":\"2019-01-22T23:34:38+00:00\",\"dateModified\":\"2019-12-10T19:55:22+00:00\",\"description\":\"We revisited Abhi Nath and his lab team to see how their work to improve the diagnosis and treatments of neurodegenerative conditions, including\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/nath-lab-makes-progress-against-neurodegenerative-conditions\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/nath-lab-makes-progress-against-neurodegenerative-conditions\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/nath-lab-makes-progress-against-neurodegenerative-conditions\\\/#primaryimage\",\"url\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/wp-content\\\/uploads\\\/AL_Hannah_Baughman_lab.jpg\",\"contentUrl\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/wp-content\\\/uploads\\\/AL_Hannah_Baughman_lab.jpg\",\"width\":1600,\"height\":1066,\"caption\":\"Hope Barnes Fellow and graduate student Hannah Baughman continues to discover more about molecular chaperones and their potential in treating Alzheimer's disease\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/nath-lab-makes-progress-against-neurodegenerative-conditions\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nath lab makes progress against neurodegenerative conditions\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#website\",\"url\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/\",\"name\":\"University of Washington School of Pharmacy\",\"description\":\"University of Washington\",\"publisher\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#organization\"},\"alternateName\":\"UW School of Pharmacy\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#organization\",\"name\":\"University of Washington School of Pharmacy\",\"alternateName\":\"UW School of Pharmacy\",\"url\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/sop.washington.edu\\\/wp-content\\\/uploads\\\/W-Logo.png\",\"contentUrl\":\"https:\\\/\\\/sop.washington.edu\\\/wp-content\\\/uploads\\\/W-Logo.png\",\"width\":526,\"height\":527,\"caption\":\"University of Washington School of Pharmacy\"},\"image\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"http:\\\/\\\/www.facebook.com\\\/UWSOP\",\"https:\\\/\\\/x.com\\\/UW_Pharmacy\",\"https:\\\/\\\/www.instagram.com\\\/uw_pharmacy\\\/\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/UWPharmacySchool\",\"https:\\\/\\\/www.linkedin.com\\\/groups\\\/3820716\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#\\\/schema\\\/person\\\/21859bae0c32073fc2c8d833a054b09f\",\"name\":\"Tim Wentzel\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nath lab makes progress against neurodegenerative conditions - School of Pharmacy","description":"We revisited Abhi Nath and his lab team to see how their work to improve the diagnosis and treatments of neurodegenerative conditions, including","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/nath-lab-makes-progress-against-neurodegenerative-conditions\/","og_locale":"en_US","og_type":"article","og_title":"Nath lab makes progress against neurodegenerative conditions - School of Pharmacy","og_description":"We revisited Abhi Nath and his lab team to see how their work to improve the diagnosis and treatments of neurodegenerative conditions, including","og_url":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/nath-lab-makes-progress-against-neurodegenerative-conditions\/","og_site_name":"School of Pharmacy","article_publisher":"http:\/\/www.facebook.com\/UWSOP","article_published_time":"2019-01-22T23:34:38+00:00","article_modified_time":"2019-12-10T19:55:22+00:00","og_image":[{"width":1600,"height":1066,"url":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-content\/uploads\/AL_Hannah_Baughman_lab.jpg","type":"image\/jpeg"}],"author":"Tim Wentzel","twitter_card":"summary_large_image","twitter_creator":"@UW_Pharmacy","twitter_site":"@UW_Pharmacy","twitter_misc":{"Written by":"Tim Wentzel","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/nath-lab-makes-progress-against-neurodegenerative-conditions\/#article","isPartOf":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/nath-lab-makes-progress-against-neurodegenerative-conditions\/"},"author":{"name":"Tim Wentzel","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#\/schema\/person\/21859bae0c32073fc2c8d833a054b09f"},"headline":"Nath lab makes progress against neurodegenerative conditions","datePublished":"2019-01-22T23:34:38+00:00","dateModified":"2019-12-10T19:55:22+00:00","mainEntityOfPage":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/nath-lab-makes-progress-against-neurodegenerative-conditions\/"},"wordCount":544,"publisher":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#organization"},"image":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/nath-lab-makes-progress-against-neurodegenerative-conditions\/#primaryimage"},"thumbnailUrl":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-content\/uploads\/AL_Hannah_Baughman_lab.jpg","articleSection":["Medchem News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/nath-lab-makes-progress-against-neurodegenerative-conditions\/","url":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/nath-lab-makes-progress-against-neurodegenerative-conditions\/","name":"Nath lab makes progress against neurodegenerative conditions - School of Pharmacy","isPartOf":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#website"},"primaryImageOfPage":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/nath-lab-makes-progress-against-neurodegenerative-conditions\/#primaryimage"},"image":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/nath-lab-makes-progress-against-neurodegenerative-conditions\/#primaryimage"},"thumbnailUrl":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-content\/uploads\/AL_Hannah_Baughman_lab.jpg","datePublished":"2019-01-22T23:34:38+00:00","dateModified":"2019-12-10T19:55:22+00:00","description":"We revisited Abhi Nath and his lab team to see how their work to improve the diagnosis and treatments of neurodegenerative conditions, including","breadcrumb":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/nath-lab-makes-progress-against-neurodegenerative-conditions\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/staff.washington.edu\/twentzel\/wordpress\/nath-lab-makes-progress-against-neurodegenerative-conditions\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/nath-lab-makes-progress-against-neurodegenerative-conditions\/#primaryimage","url":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-content\/uploads\/AL_Hannah_Baughman_lab.jpg","contentUrl":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-content\/uploads\/AL_Hannah_Baughman_lab.jpg","width":1600,"height":1066,"caption":"Hope Barnes Fellow and graduate student Hannah Baughman continues to discover more about molecular chaperones and their potential in treating Alzheimer's disease"},{"@type":"BreadcrumbList","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/nath-lab-makes-progress-against-neurodegenerative-conditions\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/"},{"@type":"ListItem","position":2,"name":"Nath lab makes progress against neurodegenerative conditions"}]},{"@type":"WebSite","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#website","url":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/","name":"University of Washington School of Pharmacy","description":"University of Washington","publisher":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#organization"},"alternateName":"UW School of Pharmacy","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#organization","name":"University of Washington School of Pharmacy","alternateName":"UW School of Pharmacy","url":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#\/schema\/logo\/image\/","url":"https:\/\/sop.washington.edu\/wp-content\/uploads\/W-Logo.png","contentUrl":"https:\/\/sop.washington.edu\/wp-content\/uploads\/W-Logo.png","width":526,"height":527,"caption":"University of Washington School of Pharmacy"},"image":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#\/schema\/logo\/image\/"},"sameAs":["http:\/\/www.facebook.com\/UWSOP","https:\/\/x.com\/UW_Pharmacy","https:\/\/www.instagram.com\/uw_pharmacy\/","https:\/\/www.youtube.com\/user\/UWPharmacySchool","https:\/\/www.linkedin.com\/groups\/3820716"]},{"@type":"Person","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#\/schema\/person\/21859bae0c32073fc2c8d833a054b09f","name":"Tim Wentzel"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/posts\/20793","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/comments?post=20793"}],"version-history":[{"count":0,"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/posts\/20793\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/media\/20794"}],"wp:attachment":[{"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/media?parent=20793"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/categories?post=20793"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/tags?post=20793"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}